Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 0 Breast Cancer AJCC v6 and v7”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Not applicableStudy completedNCT04054557
What this trial is testing

Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence

Who this might be right for
Stage 0 Breast Cancer AJCC v6 and v7Stage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+8 more
Thomas Jefferson University 305
Early research (Phase 1)Active Not RecruitingNCT03317405
What this trial is testing

Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery

Who this might be right for
Breast Ductal Carcinoma In SituBreast Lobular Carcinoma In SituStage 0 Breast Cancer AJCC v6 and v7+10 more
National Cancer Institute (NCI) 32
Not applicableStudy completedNCT03319342
What this trial is testing

Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors

Who this might be right for
Cancer SurvivorStage 0 Breast Cancer AJCC v6 and v7Stage I Breast Cancer AJCC v7+6 more
Jonsson Comprehensive Cancer Center 133
Very early researchStudy completedNCT03411070
What this trial is testing

SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer

Who this might be right for
Positive Axillary Lymph NodeStage 0 Breast Cancer AJCC v6 and v7Stage I Breast Cancer AJCC v7+9 more
Jonsson Comprehensive Cancer Center 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT01266642
What this trial is testing

Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer

Who this might be right for
Ductal Breast Carcinoma In SituInvasive Breast CarcinomaStage I Breast Cancer AJCC v6+5 more
M.D. Anderson Cancer Center 301
Testing effectiveness (Phase 2)Active Not RecruitingNCT01245712
What this trial is testing

Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer

Who this might be right for
Breast AdenocarcinomaDuctal Breast Carcinoma In SituInvasive Breast Carcinoma+7 more
M.D. Anderson Cancer Center 200
Large-scale testing (Phase 3)Temporarily pausedNCT03077841
What this trial is testing

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

Who this might be right for
Ductal Breast Carcinoma In SituEarly-Stage Breast CarcinomaInvasive Breast Carcinoma+7 more
M.D. Anderson Cancer Center 928
Large-scale testing (Phase 3)Active Not RecruitingNCT02954874
What this trial is testing

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Who this might be right for
Breast Carcinoma In SituInvasive Breast CarcinomaStage I Breast Cancer AJCC v7+3 more
National Cancer Institute (NCI) 1,155
Testing effectiveness (Phase 2)Study completedNCT02598557
What this trial is testing

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

Who this might be right for
Stage 0 Breast Cancer AJCC v6 and v7Stage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+4 more
National Cancer Institute (NCI) 180